LIGAND INTERACTION AT THE ESTROGEN-RECEPTOR TO PROGRAM ANTIESTROGEN ACTION - A STUDY WITH NONSTEROIDAL COMPOUNDS INVITRO

被引:48
作者
JORDAN, VC [1 ]
KOCH, R [1 ]
LANGAN, S [1 ]
MCCAGUE, R [1 ]
机构
[1] INST CANC RES,CANC RES CAMPAIGN LAB,SUTTON SM2 5PX,SURREY,ENGLAND
关键词
D O I
10.1210/endo-122-4-1449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1449 / 1454
页数:6
相关论文
共 18 条
[1]   PHENOL RED IN TISSUE-CULTURE MEDIA IS A WEAK ESTROGEN - IMPLICATIONS CONCERNING THE STUDY OF ESTROGEN-RESPONSIVE CELLS IN CULTURE [J].
BERTHOIS, Y ;
KATZENELLENBOGEN, JA ;
KATZENELLENBOGEN, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2496-2500
[2]   DETERMINATION OF TAMOXIFEN AND METABOLITES IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH POST-COLUMN FLUORESCENCE ACTIVATION [J].
BROWN, RR ;
BAIN, R ;
JORDAN, VC .
JOURNAL OF CHROMATOGRAPHY, 1983, 272 (02) :351-358
[3]   AGONISTIC AND ANTAGONISTIC EFFECTS OF CLOMIPHENE CITRATE AND ITS ISOMERS [J].
CLARK, JH ;
GUTHRIE, SC .
BIOLOGY OF REPRODUCTION, 1981, 25 (03) :667-672
[4]   CONTRASTING ENDOCRINE ACTIVITIES OF CIS AND TRANS ISOMERS IN A SERIES OF SUBSTITUTED TRIPHENYLETHYLENES [J].
HARPER, MJK ;
WALPOLE, AL .
NATURE, 1966, 212 (5057) :87-&
[5]   MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTI-ESTROGENIC ACTIVITY [J].
JORDAN, VC ;
COLLINS, MM ;
ROWSBY, L ;
PRESTWICH, G .
JOURNAL OF ENDOCRINOLOGY, 1977, 75 (02) :305-316
[6]   STRUCTURE ACTIVITY RELATIONSHIPS OF ESTROGENS [J].
JORDAN, VC ;
MITTAL, S ;
GOSDEN, B ;
KOCH, R ;
LIEBERMAN, ME .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1985, 61 (SEP) :97-110
[7]  
JORDAN VC, 1984, MOL PHARMACOL, V26, P279
[8]   GEOMETRIC ISOMERS OF SUBSTITUTED TRIPHENYLETHYLENES AND ANTI-ESTROGEN ACTION [J].
JORDAN, VC ;
HALDEMANN, B ;
ALLEN, KE .
ENDOCRINOLOGY, 1981, 108 (04) :1353-1361
[9]   ESTROGENIC AND ANTIESTROGENIC ACTIONS IN A SERIES OF TRIPHENYLBUT-1-ENES - MODULATION OF PROLACTIN SYNTHESIS INVITRO [J].
JORDAN, VC ;
KOCH, R ;
MITTAL, S ;
SCHNEIDER, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (01) :217-223
[10]  
JORDAN VC, 1984, MOL PHARMACOL, V26, P272